EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outcome

Maria Antonia De Francesco iD, Liana Signorini, Simone Piva, Simone Pellizzeri, Benedetta Fumarola, Silvia Corbellini, Giorgio Piccinelli, Francesca Simonetti, Valentina Carta, Lucia Mangeri, Michela Padovani, Daniela Vecchiati und 3 weitere

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28892 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Maria Antonia De Francesco und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology, Department of Molecular and Translational Medicine, ASST Spedali Civili, University of Brescia, Brescia, Italy. Hauptthemen laut MEDLINE: Bacterial Infections, Coinfection, COVID-19, Mycoses. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with viral infections are at higher risk to acquire bacterial and fungal superinfections associated with a worse prognosis. We explored this critical point in the setting of patients with severe COVID‐19 disease. The study included 1911 patients admitted to intensive care unit (ICU) during a 2‐year study period (March 2020–March 2022). Of them, 713 (37.3%) were infected with SARS‐CoV‐2 and 1198 were negative (62.7%). Regression analysis was performed to determine risk factors associated with the presence of bacterial and/or fungal superinfections in SARS‐CoV‐2 patients and to evaluate predictors of ICU mortality. Of the 713 patients with SARS‐CoV‐2 infection, 473 (66.3%) had respiratory and/or bloodstream bacterial and/or fungal superinfections, while of the 1198 COVID‐19‐negative patients, only 369 (30%) showed respiratory and/or bloodstream bacterial and/or fungal superinfections ( p < 0.0001). Baseline characteristics of COVID‐19 patients included a median age of 66 (interquartile range [IQR], 58–73), a predominance of males (72.7%), and the presence of a BMI higher than 24 (median 26; IQR, 24.5–30.4). Seventy‐four percent (527, 73.9%) had one or more comorbidities and 135 (18.9%) of them had received previous antibiotic therapy. Furthermore, most of them (473, 66.3%) exhibited severe radiological pictures and needed invasive mechanical ventilation. Multivariate logistic regression analysis showed that 1 unit increment in BMI rises the risk of bacterial and/or fungal superinfections acquisition by 3% and 1‐day increment in ICU stays rises the risk of bacterial and/or fungal superinfections acquisition by 11%. Furthermore, 1‐day increment in mechanical ventilation rises the risk of bacterial and/or fungal superinfection acquisition by 2.7 times. Furthermore, patients with both bacterial and fungal infections had a significantly higher mortality rate than patients without superinfections (45.8% vs. 26.2%, p < 0.0001). Therefore, bacterial and fungal superinfections are frequent in COVID‐19 patients admitted to ICU and their presence is associated with a worse outcome. This is an important consideration for targeted therapies in critically ill SARS‐CoV‐2 infected patients to improve their clinical course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bacterial InfectionsCoinfectionCOVID-19MycosesSARS-CoV-2AgedFemaleHumansMaleMiddle AgedIntensive Care UnitsPatient AcuityRetrospective StudiesTreatment Outcome

Stichwörter der Autor:innen

COVID-19bacteriablood infectionsfungirespiratory infectionssuperinfections

Autor:innen und Institutionen

  • Institute of Microbiology, Department of Molecular and Translational Medicine, ASST Spedali Civili, University of Brescia, Brescia, Italy.
  • Division of Infectious and Tropical Diseases, ASST Spedali Civili, University of Brescia, Brescia, Italy.
  • Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
  • Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia, Italy.
  • Department of Anesthesia, Intensive Care and Emergency, Spedali Civili University Hospital, Brescia, Italy.
  • First Division of Anesthesiology and Intensive Care Unit, ASST Spedali Civili di Brescia, Brescia, 25123, Italy.

ORCID-Profile: Maria Antonia De Francesco

Zitieren

APA

De Francesco, M. A., Signorini, L., Piva, S., Pellizzeri, S., Fumarola, B., Corbellini, S., Piccinelli, G., Simonetti, F., Carta, V., Mangeri, L., Padovani, M., Vecchiati, D., Latronico, N., Castelli, F., & Caruso, A. (2023). Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outcome. Journal of Medical Virology. https://doi.org/10.1002/jmv.28892

Vancouver

De Francesco MA, Signorini L, Piva S, Pellizzeri S, Fumarola B, Corbellini S, et al. Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outcome. Journal of Medical Virology. 2023. doi:10.1002/jmv.28892

BibTeX
@article{DeFrancesco2023,
  author = {De Francesco, Maria Antonia and Signorini, Liana and Piva, Simone and Pellizzeri, Simone and Fumarola, Benedetta and Corbellini, Silvia and Piccinelli, Giorgio and Simonetti, Francesca and Carta, Valentina and Mangeri, Lucia and Padovani, Michela and Vecchiati, Daniela and Latronico, Nicola and Castelli, Francesco and Caruso, Arnaldo},
  title = {Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV‐2 infection than negative patients and are associated to a worse outcome},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28892}
}
Kostenlos starten →